CYP19A1 and breast cancer: When co-cultured with MCF7 cells, CAAs increased the levels of CYP19A1 mRNA to upregulate the expression of aromatase, which reduced their sensitivity to the aromatase inhibitor anastrozole and promoted the growth and progression of BC [151].